Michael J. Detke - Publications

Affiliations: 
MedAvante, Hamilton Township, NJ, United States 
Area:
Drug development

59 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2015 Kiluk BD, Carroll KM, Duhig A, Falk DE, Kampman K, Lai S, Litten RZ, McCann DJ, Montoya ID, Preston KL, Skolnick P, Weisner C, Woody G, Chandler R, Detke MJ, et al. Measures of outcome for stimulant trials: ACTTION recommendations and research agenda. Drug and Alcohol Dependence. PMID 26652899 DOI: 10.1016/j.drugalcdep.2015.11.004  1
2015 Williams JB, Kobak KA, Giller E, Reasner DS, Curry L, Detke MJ. Comparison of Site-Based Versus Central Ratings in a Study of Generalized Anxiety Disorder. Journal of Clinical Psychopharmacology. PMID 26488677 DOI: 10.1097/JCP.0000000000000422  1
2014 Shen JH, Zhao Y, Rosenzweig-Lipson S, Popp D, Williams JB, Giller E, Detke MJ, Kane JM. A 6-week randomized, double-blind, placebo-controlled, comparator referenced trial of vabicaserin in acute schizophrenia. Journal of Psychiatric Research. 53: 14-22. PMID 24613032 DOI: 10.1016/j.jpsychires.2014.02.012  1
2014 Chappell JC, Eisenhofer G, Owens MJ, Haber H, Lachno DR, Dean RA, Knadler MP, Nemeroff CB, Mitchell MI, Detke MJ, Iyengar S, Pangallo B, Lobo ED. Effects of duloxetine on norepinephrine and serotonin transporter activity in healthy subjects. Journal of Clinical Psychopharmacology. 34: 9-16. PMID 24346757 DOI: 10.1097/JCP.0000000000000061  1
2014 Potter WZ, Mallinckrodt CH, Detke MJ. Controlling placebo response in drug development: Lessons learned from psychopharmacology Pharmaceutical Medicine. 28: 53-65. DOI: 10.1007/s40290-014-0052-8  1
2010 Skljarevski V, Desaiah D, Liu-Seifert H, Zhang Q, Chappell AS, Detke MJ, Iyengar S, Atkinson JH, Backonja M. Efficacy and safety of duloxetine in patients with chronic low back pain. Spine. 35: E578-85. PMID 20461028 DOI: 10.1097/BRS.0b013e3181d3cef6  1
2010 Mease PJ, Russell IJ, Kajdasz DK, Wiltse CG, Detke MJ, Wohlreich MM, Walker DJ, Chappell AS. Long-term safety, tolerability, and efficacy of duloxetine in the treatment of fibromyalgia. Seminars in Arthritis and Rheumatism. 39: 454-64. PMID 19152958 DOI: 10.1016/j.semarthrit.2008.11.001  1
2010 Mallinckrodt CH, Detke MJ, Prucka WR, Ruberg SJ, Molenberghs G. Considerations for comparing a test drug with standard of care in phase 2 clinical trials of central nervous system disorders Drug Information Journal. 44: 443-452.  1
2010 Mallinckrodt CH, Detke MJ, Prucka WR, Ruberg SJ, Molenberghs G. Design archetypes for phase 2 clinical trials in central nervous system disorders Drug Information Journal. 44: 421-430.  1
2010 Mallinckrodt CH, Detke MJ, Prucka WR, Ruberg SJ, Molenberghs G. Considerations for using positive controls in phase 2 clinical trials of central nervous system disorders Drug Information Journal. 44: 431-441.  1
2009 Skljarevski V, Desaiah D, Zhang Q, Chappell AS, Detke MJ, Gross JL, Ziegler D. Evaluating the maintenance of effect of duloxetine in patients with diabetic peripheral neuropathic pain. Diabetes/Metabolism Research and Reviews. 25: 623-31. PMID 19637208 DOI: 10.1002/dmrr.1000  1
2009 Perahia DG, Maina G, Thase ME, Spann ME, Wang F, Walker DJ, Detke MJ. Duloxetine in the prevention of depressive recurrences: a randomized, double-blind, placebo-controlled trial. The Journal of Clinical Psychiatry. 70: 706-16. PMID 19552867 DOI: 10.4088/JCP.08m04756  1
2008 Kornstein SG, Dunner DL, Meyers AL, Whitmyer VG, Mallinckrodt CH, Wohlreich MM, Detke MJ, Hollandbeck MS, Greist JH. A randomized, double-blind study of increasing or maintaining duloxetine dose in patients without remission of major depressive disorder after initial duloxetine therapy. The Journal of Clinical Psychiatry. 69: 1383-92. PMID 19193339  1
2008 Trivedi MH, Desaiah D, Ossanna MJ, Pritchett YL, Brannan SK, Detke MJ. Clinical evidence for serotonin and norepinephrine reuptake inhibition of duloxetine. International Clinical Psychopharmacology. 23: 161-9. PMID 18408530 DOI: 10.1097/YIC.0b013e3282f41d7e  1
2008 Russell IJ, Mease PJ, Smith TR, Kajdasz DK, Wohlreich MM, Detke MJ, Walker DJ, Chappell AS, Arnold LM. Efficacy and safety of duloxetine for treatment of fibromyalgia in patients with or without major depressive disorder: Results from a 6-month, randomized, double-blind, placebo-controlled, fixed-dose trial. Pain. 136: 432-44. PMID 18395345 DOI: 10.1016/j.pain.2008.02.024  1
2008 Rynn M, Russell J, Erickson J, Detke MJ, Ball S, Dinkel J, Rickels K, Raskin J. Efficacy and safety of duloxetine in the treatment of generalized anxiety disorder: a flexible-dose, progressive-titration, placebo-controlled trial. Depression and Anxiety. 25: 182-9. PMID 17311303 DOI: 10.1002/da.20271  1
2007 Mallinckrodt CH, Prakash A, Houston JP, Swindle R, Detke MJ, Fava M. Differential antidepressant symptom efficacy: placebo-controlled comparisons of duloxetine and SSRIs (fluoxetine, paroxetine, escitalopram). Neuropsychobiology. 56: 73-85. PMID 18037817 DOI: 10.1159/000111537  1
2007 Thase ME, Pritchett YL, Ossanna MJ, Swindle RW, Xu J, Detke MJ. Efficacy of duloxetine and selective serotonin reuptake inhibitors: comparisons as assessed by remission rates in patients with major depressive disorder. Journal of Clinical Psychopharmacology. 27: 672-6. PMID 18004135 DOI: 10.1097/jcp.0b013e31815a4412  1
2007 Shelton RC, Andorn AC, Mallinckrodt CH, Wohlreich MM, Raskin J, Watkin JG, Detke MJ. Evidence for the efficacy of duloxetine in treating mild, moderate, and severe depression. International Clinical Psychopharmacology. 22: 348-55. PMID 17917553 DOI: 10.1097/YIC.0b013e32821c6189  1
2007 Hudson JI, Perahia DG, Gilaberte I, Wang F, Watkin JG, Detke MJ. Duloxetine in the treatment of major depressive disorder: an open-label study. Bmc Psychiatry. 7: 43. PMID 17725843 DOI: 10.1186/1471-244X-7-43  1
2007 Shelton RC, Prakash A, Mallinckrodt CH, Wohlreich MM, Raskin J, Robinson MJ, Detke MJ. Patterns of depressive symptom response in duloxetine-treated outpatients with mild, moderate or more severe depression. International Journal of Clinical Practice. 61: 1337-48. PMID 17627710 DOI: 10.1111/j.1742-1241.2007.01444.x  1
2007 Koponen H, Allgulander C, Erickson J, Dunayevich E, Pritchett Y, Detke MJ, Ball SG, Russell JM. Efficacy of duloxetine for the treatment of generalized anxiety disorder: implications for primary care physicians. Primary Care Companion to the Journal of Clinical Psychiatry. 9: 100-7. PMID 17607331  1
2007 Mallinckrodt CH, Meyers AL, Prakash A, Faries DE, Detke MJ. Simple options for improving signal detection in antidepressant clinical trials. Psychopharmacology Bulletin. 40: 101-14. PMID 17514189  1
2007 Endicott J, Russell JM, Raskin J, Detke MJ, Erickson J, Ball SG, Marciniak M, Swindle RW. Duloxetine treatment for role functioning improvement in generalized anxiety disorder: three independent studies. The Journal of Clinical Psychiatry. 68: 518-24. PMID 17474806  1
2007 Bodkin JA, Pope HG, Detke MJ, Hudson JI. Is PTSD caused by traumatic stress? Journal of Anxiety Disorders. 21: 176-82. PMID 17055216 DOI: 10.1016/j.janxdis.2006.09.004  1
2007 Pritchett YL, Marciniak MD, Corey-Lisle PK, Berzon RA, Desaiah D, Detke MJ. Use of effect size to determine optimal dose of duloxetine in major depressive disorder. Journal of Psychiatric Research. 41: 311-8. PMID 16934840 DOI: 10.1016/j.jpsychires.2006.06.013  1
2006 Nelson JC, Lu Pritchett Y, Martynov O, Yu JY, Mallinckrodt CH, Detke MJ. The safety and tolerability of duloxetine compared with paroxetine and placebo: a pooled analysis of 4 clinical trials. Primary Care Companion to the Journal of Clinical Psychiatry. 8: 212-9. PMID 16964316  1
2006 Perahia DG, Wang F, Mallinckrodt CH, Walker DJ, Detke MJ. Duloxetine in the treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. European Psychiatry : the Journal of the Association of European Psychiatrists. 21: 367-78. PMID 16697153 DOI: 10.1016/j.eurpsy.2006.03.004  1
2006 Fava M, Detke MJ, Balestrieri M, Wang F, Raskin J, Perahia D. Management of depression relapse: re-initiation of duloxetine treatment or dose increase. Journal of Psychiatric Research. 40: 328-36. PMID 16678205 DOI: 10.1016/j.jpsychires.2005.06.005  1
2006 Perahia DG, Gilaberte I, Wang F, Wiltse CG, Huckins SA, Clemens JW, Montgomery SA, Montejo AL, Detke MJ. Duloxetine in the prevention of relapse of major depressive disorder: double-blind placebo-controlled study. The British Journal of Psychiatry : the Journal of Mental Science. 188: 346-53. PMID 16582061 DOI: 10.1192/bjp.188.4.346  1
2005 Hirschfeld RM, Mallinckrodt C, Lee TC, Detke MJ. Time course of depression-symptom improvement during treatment with duloxetine. Depression and Anxiety. 21: 170-7. PMID 16035056 DOI: 10.1002/da.20071  1
2005 Burt VK, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Stewart DE. Duloxetine for the treatment of major depressive disorder in women ages 40 to 55 years. Psychosomatics. 46: 345-54. PMID 16000678 DOI: 10.1176/appi.psy.46.4.345  1
2005 Dunner DL, D'Souza DN, Kajdasz DK, Detke MJ, Russell JM. Is treatment-associated hypomania rare with duloxetine: secondary analysis of controlled trials in non-bipolar depression. Journal of Affective Disorders. 87: 115-9. PMID 15967235 DOI: 10.1016/j.jad.2005.02.017  1
2005 Delgado PL, Brannan SK, Mallinckrodt CH, Tran PV, McNamara RK, Wang F, Watkin JG, Detke MJ. Sexual functioning assessed in 4 double-blind placebo- and paroxetine-controlled trials of duloxetine for major depressive disorder. The Journal of Clinical Psychiatry. 66: 686-92. PMID 15960560  1
2005 Goldstein DJ, Lu Y, Detke MJ, Lee TC, Iyengar S. Duloxetine vs. placebo in patients with painful diabetic neuropathy. Pain. 116: 109-18. PMID 15927394 DOI: 10.1016/j.pain.2005.03.029  1
2005 Bymaster FP, Lee TC, Knadler MP, Detke MJ, Iyengar S. The dual transporter inhibitor duloxetine: a review of its preclinical pharmacology, pharmacokinetic profile, and clinical results in depression. Current Pharmaceutical Design. 11: 1475-93. PMID 15892657 DOI: 10.2174/1381612053764805  1
2005 Thase ME, Tran PV, Wiltse C, Pangallo BA, Mallinckrodt C, Detke MJ. Cardiovascular profile of duloxetine, a dual reuptake inhibitor of serotonin and norepinephrine. Journal of Clinical Psychopharmacology. 25: 132-40. PMID 15738744 DOI: 10.1097/01.jcp.0000155815.44338.95  1
2005 Nelson JC, Wohlreich MM, Mallinckrodt CH, Detke MJ, Watkin JG, Kennedy JS. Duloxetine for the treatment of major depressive disorder in older patients. The American Journal of Geriatric Psychiatry : Official Journal of the American Association For Geriatric Psychiatry. 13: 227-35. PMID 15728754 DOI: 10.1176/appi.ajgp.13.3.227  1
2005 Brannan SK, Mallinckrodt CH, Detke MJ, Watkin JG, Tollefson GD. Onset of action for duloxetine 60 mg once daily: double-blind, placebo-controlled studies. Journal of Psychiatric Research. 39: 161-72. PMID 15589564 DOI: 10.1016/j.jpsychires.2004.05.005  1
2004 Detke MJ, Wiltse CG, Mallinckrodt CH, McNamara RK, Demitrack MA, Bitter I. Duloxetine in the acute and long-term treatment of major depressive disorder: a placebo- and paroxetine-controlled trial. European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology. 14: 457-70. PMID 15589385 DOI: 10.1016/j.euroneuro.2004.01.002  1
2004 Arnold LM, Lu Y, Crofford LJ, Wohlreich M, Detke MJ, Iyengar S, Goldstein DJ. A double-blind, multicenter trial comparing duloxetine with placebo in the treatment of fibromyalgia patients with or without major depressive disorder. Arthritis and Rheumatism. 50: 2974-84. PMID 15457467 DOI: 10.1002/art.20485  1
2004 Mallinckrodt CH, Raskin J, Wohlreich MM, Watkin JG, Detke MJ. The efficacy of duloxetine: a comprehensive summary of results from MMRM and LOCF_ANCOVA in eight clinical trials. Bmc Psychiatry. 4: 26. PMID 15355546 DOI: 10.1186/1471-244X-4-26  1
2004 Goldstein DJ, Lu Y, Detke MJ, Wiltse C, Mallinckrodt C, Demitrack MA. Duloxetine in the treatment of depression: a double-blind placebo-controlled comparison with paroxetine. Journal of Clinical Psychopharmacology. 24: 389-99. PMID 15232330 DOI: 10.1097/01.jcp.0000132448.65972.d9  1
2004 Fava M, Mallinckrodt CH, Detke MJ, Watkin JG, Wohlreich MM. The effect of duloxetine on painful physical symptoms in depressed patients: do improvements in these symptoms result in higher remission rates? The Journal of Clinical Psychiatry. 65: 521-30. PMID 15119915 DOI: 10.4088/JCP.v65n0411  1
2004 Goldstein DJ, Lu Y, Detke MJ, Hudson J, Iyengar S, Demitrack MA. Effects of duloxetine on painful physical symptoms associated with depression. Psychosomatics. 45: 17-28. PMID 14709757 DOI: 10.1176/appi.psy.45.1.17  1
2004 Mallinckrodt CH, Kaiser CJ, Watkin JG, Detke MJ, Molenbergs G, Carroll RJ. Type 1 error rates from likelihood-based repeated measures analyses of incomplete longitudinal data Pharmaceutical Statistics. 3: 171-186. DOI: 10.1002/pst.131  1
2003 Dunner DL, Goldstein DJ, Mallinckrodt C, Lu Y, Detke MJ. Duloxetine in treatment of anxiety symptoms associated with depression. Depression and Anxiety. 18: 53-61. PMID 12964171 DOI: 10.1002/da.10122  1
2003 Fishbain DA, Detke MJ. Analgesic effect of antidepressants [2] (multiple letters) Journal of Clinical Psychiatry. 64: 96-97. PMID 12590632  1
2002 Detke MJ, Lu Y, Goldstein DJ, McNamara RK, Demitrack MA. Duloxetine 60 mg once daily dosing versus placebo in the acute treatment of major depression. Journal of Psychiatric Research. 36: 383-90. PMID 12393307 DOI: 10.1016/S0022-3956(02)00060-2  1
2002 Carlezon WA, Pliakas AM, Parow AM, Detke MJ, Cohen BM, Renshaw PF. Antidepressant-like effects of cytidine in the forced swim test in rats. Biological Psychiatry. 51: 882-9. PMID 12022961 DOI: 10.1016/S0006-3223(01)01344-0  1
2002 Detke MJ, Lu Y, Goldstein DJ, Hayes JR, Demitrack MA. Duloxetine, 60 mg once daily, for major depressive disorder: a randomized double-blind placebo-controlled trial. The Journal of Clinical Psychiatry. 63: 308-15. PMID 12000204  1
2002 Chalon S, Bieck PR, Goldstein DJ, Detke MJ, Bymaster FP, Potter WZ, Demitrack MA. The tyramine pressor test may have limited sensitivity, especially in the presence of dual serotonin/norepinephrine uptake inhibition. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 26: 698-9; author reply . PMID 11927196 DOI: 10.1016/S0893-133X(01)00409-2  1
1999 Page ME, Detke MJ, Dalvi A, Kirby LG, Lucki I. Serotonergic mediation of the effects of fluoxetine, but not desipramine, in the rat forced swimming test. Psychopharmacology. 147: 162-7. PMID 10591883  1
1997 Detke MJ, Johnson J, Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Experimental and Clinical Psychopharmacology. 5: 107-12. PMID 9234045 DOI: 10.1037/1064-1297.5.2.107  1
1996 Detke MJ, Lucki I. Detection of serotonergic and noradrenergic antidepressants in the rat forced swimming test: the effects of water depth. Behavioural Brain Research. 73: 43-6. PMID 8788475 DOI: 10.1016/0166-4328(96)00067-8  1
1995 Detke MJ, Rickels M, Lucki I. Active behaviors in the rat forced swimming test differentially produced by serotonergic and noradrenergic antidepressants. Psychopharmacology. 121: 66-72. PMID 8539342 DOI: 10.1007/BF02245592  1
1995 Detke MJ, Wieland S, Lucki I. Blockade of the antidepressant-like effects of 8-OH-DPAT, buspirone and desipramine in the rat forced swim test by 5HT1A receptor antagonists. Psychopharmacology. 119: 47-54. PMID 7675949 DOI: 10.1007/BF02246053  1
1991 Detke MJ. Extinction of sequential conditioned inhibition Animal Learning & Behavior. 19: 345-354. DOI: 10.3758/BF03197895  1
1989 Detke MJ, Brandon SE, Weingarten HP, Rodin J, Wagner AR. Modulation of behavioral and insulin responses by contextual stimuli paired with food. Physiology & Behavior. 45: 845-51. PMID 2675142 DOI: 10.1016/0031-9384(89)90305-3  1
Show low-probability matches.